Policy submissions

SHPA is committed to promoting best practice medicines management and fostering a greater understanding and appreciation of the key role hospital pharmacists, and pharmacists working in other healthcare settings, play in delivering evidence-based healthcare.

We utilise the evidence generated by research, the clinical leadership of SHPA’s Specialty Practice Committees and Reference Groups, and the expertise of members who provide quality healthcare at the coalface, to provide advice and input into policy development at federal and jurisdictional levels.

Reflecting members’ diverse and innovative roles, SHPA has a comprehensive understanding of the multiple funding and regulatory frameworks with respect to medicines and welcomes the opportunity to engage with governments and other stakeholders.

Policy submissions

SHPA develops submissions to government and stakeholder consultations which express SHPA’s positions on important issues that have the potential to impact medicines management, access to medicines and the well-being of Australian consumers. 

View position statements.
View clinical medicine submissions.

Advocacy publications

• Reducing opioid-related harm: A hospital pharmacy landscape paper for the Medicines Leadership Forum - July 2018
• Medicine shortages in Australia: A snapshot of shortages in Australian hospitals - June 2017

For more information about SHPA’s policy work contact Jerry Yik, Senior Policy Analyst